GB2166637A - Drink concentrate - Google Patents
Drink concentrate Download PDFInfo
- Publication number
- GB2166637A GB2166637A GB08425093A GB8425093A GB2166637A GB 2166637 A GB2166637 A GB 2166637A GB 08425093 A GB08425093 A GB 08425093A GB 8425093 A GB8425093 A GB 8425093A GB 2166637 A GB2166637 A GB 2166637A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- drink
- drink concentrate
- concentrate
- hydrogenated starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/35—Starch hydrolysates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
There is disclosed a drink concentrate comprising an acceptable non-cariogenic hydrogenated starch hydrolysate, vitamin C, citric acid, and appropriate flavouring, and may comprise further vitamins. A drink may be made by diluting the concentrate with water.
Description
SPECIFICATION
Drink Concentrate
The present invention relates to drink concentrates.
Dental caries (localized tooth decay caused by the metabolic products of micro-organisms) is one of the most widespread diseases to be found, especially in children, affecting almost 100% of the population. The damage is caused by sticking colonies of bacteria, notably Streptococcus Mutans and certain of the lactobacilli, adhering to the teeth and producing acid, which causes the decay.
The appearance of these gelatinous colonies, or plaques, has been directly linked with the intake of dietary carbohydrates, the most effective being sucrose which is also the most common. Sucrose is a disaccharide, each molecule consisting of a combination of one molecule of a fructose derivative joined with one molecule of a glucose derivative. This disaccharide is metabolized by
Streptococcus Mutans both intracellularly and extracellularly. When broken down extracellularly the resulting glucose and fructose molecules are homogenically polymerised to form long chain glucans (glucose produces dextrans and fructose produces levans). These polysaccha rides form the adhesive capsule around the cells which aliows the bacteria to cling together and to the teeth.
The intracellular anaerobic breakdown of sucrose leads to the production of acid, notably lactic acid.
This is excreted by the cells, and it is protected from the buffering action of saliva by the layer of glycans laid down by the bacteria. Further lactic acid is produced by lactobacilli also present in the plaque.
It is this acid which demineralises and rots the tooth beneath the plaque and causes dental caries.
It is thus inevitable that children with the predilection for all sweet food and drink, should be most affected by this disease. Their high intake of sucrose combined with their inherent reluctance to clean their teeth leads to a high incidence of dental caries. Possibly the most serious manifestation of this disease is found in "nursing bottle syndrome".
This occurs when infants have been given bottles of sweet drinks to reduce their noise levels and the high intake of carbohydrate that this practice entails causes widespread damage to and destruction of most of the child's teeth.
This situation is further exacerbated by the use of "health drinks". These drinks are marketed to give, e.g. children, a useful supplement of vitamins and minerals to their daily diet. However, to make these drinks palatable enough for the children to accept them, they are very sweet, and thus their use contributes greatly to the incidence of caries in children.
Thus, for some time the industry has been concerned with producing a sweet drink preferably of the formulation currently thought of as a "health drink", which does not cause significant decay of the teeth of the consumer.
The cariogenic (caries-inducing) properties of many commercial sweeteners are now known, and almost all cause less decay than sucrose. This is due to the inability of the bacteria to metabolize them
adequately, if at all, thus producing little acid and
less glycans.
However, so far, drinks formulated using
sweeteners in place of sucrose have exhibited a
variety of drawbacks. In the case of the well known
sweetener saccharin, the drink was found to be
unpalatable because of the unpleasant aftertaste,
whilst another well known sweetener, sorbitol,
which is very non-cariogenic, caused diarrhoea in
those infants to whom it was administered. Thus,
until now, no palatable non-cariogenic health drink
had been successfully formulated.
The use of hydrogenated starch hydrolysates
such as sorbitol as sweeteners is well known. These
hydrolysates are glucose-based, all the glucose
units with free aldehyde groups having been
reduced by hydrogenation. Until recently, however,
those hydrolysates which possessed "body",
without a too pronounced hygroscopic character,
were found to be cariogenic. As these were the only
hydrogenated starch hydrolysates capable of being
used in the manufacture of food products, they were
not widely employed.
It was then found that such a hydrolysate was
cariogenic because it contained a large proportion
of polyols with a degree of polymerization (DP)
greater than 20. Those hydrolysates which
contained small quantities of these polyols were
found to have large amounts of low molecular
weight products, notably of DP1 and 2.
A hydrogenated starch hydrolysate was then
formulated which contained less than 3% by weight
of polyols of DP greater than 20, up to 60% by
weight of manitol (DP2), less than 19% by weight of
sorbitol (DP1), and the balance to 100% being
constituted by polyols of DP3 to 20 (U.K. Patent No.
GB-2038832 B).
A syrup made from such a hydrolysate and sold
under the Registered Trade Mark "LYCASIN" has
about 0.75 the sweetness of sucrose, is considerably
less cariogenic than sucrose (which is
approximately two to three times more cariogenic),
and has sufficient "body" for inclusion in food
products.
The hydrogenated starch hydrolysates suitability
for inclusion into a low-cariogenic drink is increased
due to its lack of after affects, its ready metabolism
by the human gut and its calorific value, the
equivalent of sucrose. Its non-cariogenic properties
are further enhanced by the fact that, due to its
lower sweetness, less citric acid need be included in
the drink than is found in those formulated with
sucrose. Thus, in addition to promoting bacterial
decay less than those drinks formulated with
sucrose, any drink formulated with such a
hydrolysate would cause less direct damage to
teeth.
According to the present invention there is
provided a drink concentrate, comprising an
acceptable non-cariogenic hydrogenated starch
hydrolysate, vitamin C, citric acid, and appropriate
flavouring. Optionally the concentrate may include
water. If desired the concentrate may include other
vitamins in addition to vitamin C.
Preferably the drink is formulated so as to be considered a "health drink", and more preferably is suitable for use with infants.
The non-cariogenic hydrogenated starch hydrolysate suitable for use in the drink concentrate of the present invention is one which contains:
less than 3% by weight of polyols of DP higher than 20;
up to 60% by weight of maltitol (DP 2); lessthan 19% byweightofsorbitol (DP 11);
the balance to 100% being constituted by polyols of DP3 to 20.
The hydrolysate is normally used in the form of a syrup ofthe hydrolysate in water.
Preferably the hydrolysate contains:
35% to 60% by weight of maltitol, and
0.1 to 17% byweightofsorbitol,and more
preferably,
less than 1.5% by weight of polyols of DP higher than 20;
40 to 55% by weight of maltitol, and 0.3 to 14% byweightofsorbitol.
The concentrate may contain water.
Preferably the concentrate comprises from 75 to
99% by weight hydrogenated starch hydrolysate
syrup, preferably 87% by weight; from 6 to 18% by weightflavouring, preferably 12% by weight; from 0.2 to 1% byweightvitamin C, preferably 0.6% by weight; and from 1.6 to 6.4% by weight citric acid,
preferably 0.4% by weight.
Water should normally be added to dilute the
product before consumption. The invention thus
also provides a drink comprising the drink
concentrate of the invention and water.
The invention will now be further described by
reference to the following Examples, in which all
percentages given are percentages by weight.
Lycasin 80/55 is a product comprising
hydrogenated homologues of dextrose and the
dextrose oligomers present in a specific corn starch
obtained by enzymic hydrolysis. The composition of
the solid Lycasin 80/55 is shown in Table 1, and some of the properties of Lycasin 80/55 in syrup form are shown in Table 2.
The syrup is clear, colourless and odourless. It does not crystallize at low temperatures or high concentrations, and the glucose syrups inhibits cyrstallization of other components of any product in which it is included. It is more viscous than sucrose syrup of the same concentration, and its viscosity decreases steeply as the temperature increases. The syrup is considerably less hydroscopic than the solid and thus is easier to work with in food manufacture.
TABLE 1
Typical analysis of the composition of dry Lycasin
80/55
Component % Present.
DP1 (Sorbitol) 7.0
DP 2 (Maltitol) 52.5
DP 3 17.5 DP4 1.0
DP 5 2.0
DP 6 2.5
DP 7 3.5
DP 8 2.2
DP 9 1.0 DP10 1.0
From DP 11 to DP 20 9.0 Greaterthan DP 20 0.8
TABLE 2
Lycasin 80/55 specification
Dry substance 75% + 1 Refractive index
at 20"C 1.4762-1.4815 Specific gravity
at 20"C 1.36
Reducing sugars 0.2% maximum
Specification rotation a" +115"120" Viscosity (75%
solid) 2000 cP pH in solution
Resistivity 500,000 ohm-cm min
Sulphated ash 0.1% maximum
Sulphate 100 mg Keg~1 maximum
Chloride 50 mg Kg-' maximum
Heavy metals 10 mg Kg-' maximum
Nickel 1 mg Kg- maximum
In the Examples which follow the Lycasin 80/55 is used in syrup form.
EXAMPLE 1
A blackcu rrant flavoured health drink concentrate for use e.g. as a baby syrup formulated as follows: "Lycasin 80/55" : 91.6% Blackcurrant juice
(appres.) 01490
(Barnett & Foster Ltd.) or Blackcurrantjuice 16166
(Barnett & Foster Ltd.)
8.0%
Vitamin C : 0.4%
Citric acid is contained in the flavouring used.
EXAMPLE 2
An apple-flavoured health drink concentrate for use e.g. as a baby syrup was formulated as follows: "Lycasin 80/55" . 87.2%
Apple juice conc. 24059
(Barnett & Foster Ltd.) 6.0%
Natural Apple flavour 22295
(Barnett & Foster Ltd.) : 6.0% Vitamin C 0.4% Citric acid 0.4%
EXAMPLE 3
An orange flavoured health drink concentrate for use e.g. as a baby syrup was formulated as follows: "Lycasin 80/55" : 82.44%
Orange juice conc. : 16.8% Vitamin C : 0.4%
Natural Orange booster
flavour 22912 0.2%
(Barnett & Foster Ltd.)
Citric acid 0.16%
EXAMPLE 4
An orange and apricot flavoured health drink concentrate for use e.g. as a baby syrup was formulated as follows: "Lycasin 80/55" : 82.24%
Orange conc. : 16.60%
Apricot flavour E41926
(Fries & Fries) 0.4%
Vitamin C 0.4%
Orange booster flavour 22912
(Barnett & Foster Ltd.) 0.2%
Citric acid : 0.16%
EXAMPLE 5
An orange and pineapple flavoured health drink concentrate for use e.g. as a baby syrup was formulated as follows: "Lycasin 80/55" : 80.96%
Orange conc. : 16.6%
Pineapple flavour 1.68%
Vitamin C 0.4%
Orange booster flavour 22912
(Barnett & Foster Ltd.) 0.2%
Citric acid 0.16%
Claims (17)
1. A drink concentrate comprising an acceptable non-cariogenic hydrogenated starch hydrolysate, vitamin C, citric acid and flavouring.
2. A drink concentrate as claimed in claim 1 further comprising water.
3. A drink concentrate as claimed in claims 1 or 2 further comprising other vitamins.
4. A drink concentrate as claimed in any of the preceding claims wherein the hydrogenated starch hydrolysate comprises no more than 3% by weight of polyols of DP higher than 20, no more than 60% byweightofmaltitol (DP2) and no more than 19% by weight of sorbitol (DP 11), with the balance to 100%.
5. A drink concentrate as claimed in claim 4 wherein the hydrogenated starch hydrolysate comprises from 35% to 60% by weight of maltitol and 0.1 to 17% sorbitol.
6. A drink concentrate as claimed in claim 5 wherein the hydrogenated starch hydrolysate comprises from 40 to 55% by weight of maltitol, from 0.3to 14% by weight of sorbitol and up to 1.5% by weight of polyols of DP higher than 20.
7. A drink concentrate as claimed in any of the preceding claims wherein the hydrogenated starch hydrolysate is in the form of a syrup.
8. A drink concentrate as claimed in claim 7 comprising from 75 to 99% by weight of hydrogenated starch hydrolysate syrup.
9. A drink concentrate as claimed in claim 8 comprising 87% by weight of hydrogenated starch hydrolysate syrup.
10. A drink concentrate as claimed in any of the preceding claims comprising from 6 to 18% by weight of flavouring.
11. A drink concentrate as claimed in claim 10 comprising 12% by weight of flavouring.
12. A drink concentrate as claimed in any of the preceding claims comprising from 0.2 to 1% by weight of vitamin C.
13. A drink concentrate as claimed in claim 12 comprising 0.6% by weight of vitamin C.
14. A drink concentrate as claimed in any of the preceding claims comprising from 1.6 to 6.4 % by weight of citric acid.
15. A drink concentrate as claimed in claim 14 comprising 0.4% by weight of citric acid.
16. A drink comprising a drink concentrate as claimed in any of the preceding claims and water.
17. A drink concentrate substantially as hereinbefore described with reference to the accompanying Examples.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08425093A GB2166637A (en) | 1984-10-04 | 1984-10-04 | Drink concentrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08425093A GB2166637A (en) | 1984-10-04 | 1984-10-04 | Drink concentrate |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8425093D0 GB8425093D0 (en) | 1984-11-07 |
GB2166637A true GB2166637A (en) | 1986-05-14 |
Family
ID=10567702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08425093A Withdrawn GB2166637A (en) | 1984-10-04 | 1984-10-04 | Drink concentrate |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2166637A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2654308A1 (en) * | 1989-11-13 | 1991-05-17 | Roquette Freres | CONCENTRATED SWEETENING COMPOSITION FOR USE IN FOOD PRODUCTS. |
US5141758A (en) * | 1991-11-13 | 1992-08-25 | Monte Woodrow C | Method for extending life of vitamin C in drink |
US11253474B1 (en) | 2021-02-01 | 2022-02-22 | Liqmeds Worldwide Limited | Pharmaceutical solution of amlodipine |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1024408A (en) * | 1964-10-30 | 1966-03-30 | Sandoz Products Ltd | Improvements in or relating to beverage concentrates |
GB1169538A (en) * | 1965-11-29 | 1969-11-05 | Lyckeby Staerkelsefoeraedling | Sugar Substitute and a Process for the Preparation thereof |
GB1250952A (en) * | 1968-01-23 | 1971-10-27 | ||
GB1277393A (en) * | 1969-09-17 | 1972-06-14 | Merck & Co Inc | Beverages containing vitamin c |
GB2038832A (en) * | 1978-12-11 | 1980-07-30 | Roquette Freres | Non-cariogenic hydrogenated starch hydrolysate process for its preparation and uses thereof |
GB2064938A (en) * | 1979-10-05 | 1981-06-24 | Gawen P | Energy-providing drink suitable for diabetics |
GB2097004A (en) * | 1981-02-12 | 1982-10-27 | Hayashibara Biochem Lab | Crystalline anhydrous maltitol |
-
1984
- 1984-10-04 GB GB08425093A patent/GB2166637A/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1024408A (en) * | 1964-10-30 | 1966-03-30 | Sandoz Products Ltd | Improvements in or relating to beverage concentrates |
GB1169538A (en) * | 1965-11-29 | 1969-11-05 | Lyckeby Staerkelsefoeraedling | Sugar Substitute and a Process for the Preparation thereof |
GB1250952A (en) * | 1968-01-23 | 1971-10-27 | ||
GB1277393A (en) * | 1969-09-17 | 1972-06-14 | Merck & Co Inc | Beverages containing vitamin c |
GB2038832A (en) * | 1978-12-11 | 1980-07-30 | Roquette Freres | Non-cariogenic hydrogenated starch hydrolysate process for its preparation and uses thereof |
GB2064938A (en) * | 1979-10-05 | 1981-06-24 | Gawen P | Energy-providing drink suitable for diabetics |
GB2097004A (en) * | 1981-02-12 | 1982-10-27 | Hayashibara Biochem Lab | Crystalline anhydrous maltitol |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2654308A1 (en) * | 1989-11-13 | 1991-05-17 | Roquette Freres | CONCENTRATED SWEETENING COMPOSITION FOR USE IN FOOD PRODUCTS. |
EP0431995A1 (en) * | 1989-11-13 | 1991-06-12 | Roquette Frˬres | Concentrated sweetening composition suitable for foodstuff |
US5141758A (en) * | 1991-11-13 | 1992-08-25 | Monte Woodrow C | Method for extending life of vitamin C in drink |
US11253474B1 (en) | 2021-02-01 | 2022-02-22 | Liqmeds Worldwide Limited | Pharmaceutical solution of amlodipine |
US11458095B2 (en) | 2021-02-01 | 2022-10-04 | Liqmeds Worldwide Limited | Pharmaceutical solution of amlodipine |
US11723866B2 (en) | 2021-02-01 | 2023-08-15 | Liqmeds Worldwide Limited | Pharmaceutical solution of amlodipine |
US12005141B2 (en) | 2021-02-01 | 2024-06-11 | Liqmeds Worldwide Limited | Pharmaceutical solution of amlodipine |
Also Published As
Publication number | Publication date |
---|---|
GB8425093D0 (en) | 1984-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gupta | Sugar substitutes: mechanism, availability, current use and safety concerns-an update | |
US4681771A (en) | Sweetener | |
Ly et al. | Xylitol, sweeteners, and dental caries | |
AU724947B2 (en) | Method of increasing the sweetening power and enhancing the taste of a mixture of high-intensity sweeteners | |
Lynch et al. | Xylitol and dental caries: an overview for clinicians | |
DE68905217T2 (en) | USE OF SUGARY, LOW-CALORIE PRODUCTS LIKE OLIGOFRUCTOSYL SACCHARIDES AND FOOD PRODUCTS OR BEVERAGES OR DIAETAL PRODUCTS CONTAINING THE SAME. | |
Peldyak et al. | Xylitol for caries prevention. | |
EP0009325A1 (en) | Erythritol cointaining anti-caries compositions | |
Zacharis | Xylitol | |
EP2769628A1 (en) | Carbohydrate compositions | |
AU718640B2 (en) | use of oligosaccharides to increase the sweetening power and enhance the taste of an acesulfame-K/aspartame mixture | |
GB2166637A (en) | Drink concentrate | |
Billaux et al. | Sugar alcohols | |
Antonik et al. | Characteristics of sweeteners used in foods and their effects on human health | |
Yadav et al. | Sugar substitutes and health | |
JPH035788B2 (en) | ||
JPH04311378A (en) | Polyfructan-containing liquid composition | |
JP2832038B2 (en) | New food materials | |
RU2216208C2 (en) | Sweetener for food products | |
JP2832037B2 (en) | Food material | |
Shaw | The role of sugar in the aetiology of dental caries: 6. Evidence from experimental animal research | |
Morozova et al. | Food components in oral health | |
JP2903480B2 (en) | Frozen dessert using reduced xylo-oligosaccharide | |
JPH1189524A (en) | Gummy jelly confectionery | |
JPH0284142A (en) | Lactitol-containing jams |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |